- CMI Unit 707 Organisational Design and Development (J/617/6867) Assignment Brief 2026
- CMI Unit 705 Leading Strategic Change (A/617/6865) Assignment Brief 2026
- CMI Unit 703 Collaboration and Partnerships (M/617/6863) Assignment Brief 2026
- CMI Unit 701 Strategic Leadership (H/617/6861) Assignment Brief 2026
- DPM712 Finance for Project Managers (K/651/6509) Assignment Brief 2026
- DPM710 Innovation in Project Management (H/650/6850) Assignment Brief 2026
- DPM708 Leadership and Professional Development (Y/650/6848) Assignment Brief 2026
- DPM706 Principles of Project Management (T/650/6847) Assignment Brief 2026
- DPM704 Operations and Information Management for Project Managers (A/650/3760) Assignment Brief 2026
- DPM702 Procurement Risk and Contract Management (L/650/3757) Assignment Brief 2026
- DPM711 Project Management (J/650/6851) Assignment Brief 2026
- DPM709 Managing Risk, Uncertainty and Complexity in Projects (A/650/6849) Assignment Brief 2026
- DPM707 Operations and Global Supply Chain Management (R/650/6558) Assignment Brief 2026
- DPM705 Research Methods for Project Management (D/650/3761) Assignment Brief 2026
- DPM703 Project and Logistics Management (R/650/3759) Assignment Brief 2026
- DPM701 Planning, Controlling and Leading a Project (J/650/3755) Assignment Brief 2026
- MOD011086 Population Healthcare and Health Improvement Assignment Brief 2026
- Research Methods in Education (M/617/5003) Assignment Brief 2026
- Pedagogy and Practice in Education (H/617/5001) Assignment Brief 2026
- The Management of Educational Change (A/617/4999) Assignment Brief 2026
You are working within the pharmaceutical industry, and you have been assigned a kinase to develop an inhibitor for: Medicinal Chemistry Assignment, UniS, UK
| University | University Of Surrey (UniS) |
| Subject | Medicinal Chemistry |
You are working within the pharmaceutical industry, and you have been assigned a kinase to develop an inhibitor for. Your team has already found a compound that can moderate the activity of the kinase of interest.
- Using this information, use AutoDockTools and Autodock Vina to dock your compound with the kinase of interest. Your report should include
- A brief explanation of how you determine the search area for the docking, accompanied by a suitable picture to show where the search box is located with respect to the kinase in your docking.
You can click “Ligand Interaction” which will bring you to a new page displaying where and how a drug molecule interacts with the kinase. You can use your mouse to rotate and zoom in/out to help you visualize the binding site.
Once you have a good understanding of where the binding site should be, you need to adjust the dimensions, scaling factor, and the center of the search box in AutoDockTools based on this information. You need to make sure you define the search box correctly in your conf.txt file. - Description of possible interactions between your compound and the kinase that you have identified after docking, accompanied by a suitable picture and labeling to highlight the interactions.
- A table to show the binding affinity of your compound and the kinase from docking.
- Based on the results from the molecular docking, and also using your knowledge of medicinal chemistry, make FIVE changes you would make to the molecule in order to probe SAR and increase binding efficiency. Your answer should be a maximum of ONE A4 page in length, should concisely describe why you are making those changes, and should include chemical drawings of your hit compound and subsequent analogs in order to visualize those changes.
Buy Answer of This Assessment & Raise Your Grades
Answer



